Endo Pharmaceuticals INC.
Speciality healthcare solutions company.
Based in DC
🤖
AI Overview
With $20K in lobbying spend across 1 quarterly filings, Endo Pharmaceuticals INC is an active lobbying client. Their lobbying covers 4 issue areas.
$20K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $20K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Copyright/Patent, Health Issues, Taxation, Torts
- •Oversight of implementation of the America Invents Act.
- •Issues relating to patent settlements.
- •Patent reform.
- •Issues relating to misuse of the inter pares review process.
- •Issues relating to prescription drug abuse.
- •Issues relating to incentives for tamper-resistant formulations.
- •Issues relating to FDA approvals of new drugs and generic drugs.
- •Issues related to the FDA.
- •Issues relating to incentives for life sciences research.
- •Tax treatment of inverted companies.
- •Tax issues in mergers and acquisitions of US firms.
- •Issues relating to Mass Torts and Class Action Reform.
Related Analysis
Related Investigations
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.